Myovant Sciences Ltd. logo
Myovant Sciences Ltd. MYOV

Quarterly report 2022-Q4
added 01-26-2023

report update icon

Myovant Sciences Ltd. Accounts Receivables 2011-2026 | MYOV

Accounts receivable — is the amount of money owed to a company by other organizations, individuals, or the government. It arises when a company has already delivered goods, performed work, or provided services, but has not yet received payment for them.
Examples of accounts receivable
  • Customers have not paid invoices for delivered products
  • An advance has been paid to a supplier, but goods have not yet been received
  • Employees have not reported on accountable amounts
  • The government must refund tax overpayments
  • Outstanding loans issued
Importance of accounts receivable in company analysis
  1. Asset quality
    Accounts receivable are part of current assets. But they are not cash — they are promises. Investors assess how realistic these promises are to be collected. The higher the share of overdue or doubtful receivables, the greater the risk of asset impairment.
  2. Impact on cash flow
    Even if a company shows a profit, the money can be "tied up" in receivables. This means profit does not turn into actual cash, and the company may face liquidity shortages.
  3. Assessment of management efficiency
    The following accounts receivable turnover ratios are commonly used:
    Receivables turnover = Revenue / Average accounts receivable
    (the higher — the better)

    Days Sales Outstanding (DSO) = 365 / Turnover
    (the fewer days — the faster customers pay)

    If the DSO is constantly increasing — this is a red flag — customers are delaying payments, and money gets stuck in settlements.

Annual Accounts Receivables Myovant Sciences Ltd.

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
3.57 M - - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
3.57 M 3.57 M 3.57 M

Quarterly Accounts Receivables Myovant Sciences Ltd.

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
41 M 33.8 M - 23.3 M 18.9 M 14.4 M 10.6 M 3.57 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
41 M 3.57 M 20.8 M

Accounts Receivables of other stocks in the Biotechnology industry

Issuer Accounts Receivables Price % 24h Market Cap Country
Ultragenyx Pharmaceutical Ultragenyx Pharmaceutical
RARE
158 M $ 19.23 -3.85 % $ 1.9 B usaUSA
Regeneron Pharmaceuticals Regeneron Pharmaceuticals
REGN
5.74 B $ 742.02 -1.94 % $ 77.6 B usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
57 K - -10.17 % $ 12.2 K usaUSA
AIkido Pharma AIkido Pharma
AIKI
200 K - 1.93 % $ 17.4 M usaUSA
I-Mab I-Mab
IMAB
130 M - - $ 866 M chinaChina
Albireo Pharma Albireo Pharma
ALBO
3.27 M - -0.23 % $ 916 M usaUSA
REGENXBIO REGENXBIO
RGNX
28.7 M $ 7.88 -4.6 % $ 406 M usaUSA
Aptinyx Aptinyx
APTX
257 K - -39.0 % $ 4.57 M usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
1.65 M - -6.81 % $ 3.04 B usaUSA
Rigel Pharmaceuticals Rigel Pharmaceuticals
RIGL
51.8 M $ 26.2 -0.64 % $ 471 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
234 K - - $ 7.46 M israelIsrael
Avidity Biosciences Avidity Biosciences
RNA
2.36 M $ 13.09 -0.08 % $ 1.8 B usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
17.3 M - -24.86 % $ 820 K usaUSA
bluebird bio bluebird bio
BLUE
300 K - - $ 546 M usaUSA
Acasti Pharma Acasti Pharma
ACST
802 K - 4.01 % $ 150 M canadaCanada
Avid Bioservices Avid Bioservices
CDMO
16.6 M - - $ 789 M usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
886 K - - $ 86.2 M usaUSA
Advaxis Advaxis
ADXS
234 K - -9.65 % $ 45.9 M usaUSA
Rhythm Pharmaceuticals Rhythm Pharmaceuticals
RYTM
26.1 M $ 78.52 -4.13 % $ 5.1 B usaUSA
Adaptive Biotechnologies Corporation Adaptive Biotechnologies Corporation
ADPT
50.4 M $ 12.57 -9.96 % $ 1.91 B usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
865 M - 0.49 % $ 251 B cayman-islandsCayman-islands
SIGA Technologies SIGA Technologies
SIGA
3.26 M $ 5.35 7.76 % $ 383 M usaUSA
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
778 M $ 321.71 -1.96 % $ 42.1 B usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
56.9 M - -4.8 % $ 255 M usaUSA
Cara Therapeutics Cara Therapeutics
CARA
2.76 M - -3.03 % $ 260 M usaUSA
ChemoCentryx ChemoCentryx
CCXI
411 K - - $ 3.74 B usaUSA
Enlivex Therapeutics Ltd. Enlivex Therapeutics Ltd.
ENLV
28 K $ 1.08 -0.92 % $ 22.2 M israelIsrael
Enochian Biosciences Enochian Biosciences
ENOB
432 K - - $ 40.5 M usaUSA